This program supports mid-career scientists conducting high-risk, high-reward research at the forefront of cancer immunotherapy. It empowers bold thinkers to develop transformative approaches to cancer treatment, providing substantial funding to advance innovative immunotherapy projects.
Open to mid-career scientists engaged in high-risk, high-reward cancer immunotherapy research. Applicants must be pursuing leading-edge projects in this field.
